Carlos F. Barbas III, Ph.D., professor at The Scripps Research Institute, has been named one of the winners of the National Institutes of Health's 2010 Director's Pioneer Awards, which includes a research budget of up to $500,000 in direct costs per year for five years.
Barbas is one of 17 scientists named by NIH Director Francis S. Collins, M.D., Ph.D., as new recipients of the prize, designed to give awardees the intellectual freedom to pursue groundbreaking new research directions.
Barbas, who holds the Janet and Keith Kellogg II Chair in Molecular Biology and Chemistry and joint appointments in the Departments of Molecular Biology and Chemistry and the Skaggs Institute for Chemical Biology at Scripps Research, was selected for the award on the basis of his proposal that concerns chemically programming immunity, research that could lead to "instant immunity" vaccines for the flu, HIV-1, and cancer.
The new approach would overcome a major drawback of current vaccinations - the lag time of days, or even weeks, that it normally takes for immunity to build against pathogens such as bacteria and viruses.
SOURCE: Press Release